True Wealth Design’s Nuvation Bio NUVB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$6.27K Buy
1,119
+8
+0.7% +$50 ﹤0.01% 1254
2026
Q2
$6.31K Sell
1,111
-3
-0.3% -$15 ﹤0.01% 1238
2026
Q1
$4.78K Hold
1,114
– – ﹤0.01% 1232
2025
Q4
$9.98K Hold
1,114
– – ﹤0.01% 868
2025
Q3
$4.12K Buy
1,114
+387
+53% +$1.05K ﹤0.01% 1156
2025
Q2
$1.42K Buy
727
+709
+3,939% +$1.48K ﹤0.01% 1321
2025
Q1
$32 Sell
18
-48
-73% -$109 ﹤0.01% 2499
2024
Q4
$176 Sell
66
-495
-88% -$1.27K ﹤0.01% 1234
2024
Q3
$1.28K Buy
+561
New +$1.71K ﹤0.01% 908

Other funds holding NUVB

True Wealth Design's NUVB Position: Q3 2026 in Review

True Wealth Design increased its Nuvation Bio (NUVB) stake by 0.72% in Q3 2026, buying an estimated $50 and bringing the position to 1,119 shares worth $6.27K. The position accounts for ﹤0.01% of the portfolio, ranked #1254.

True Wealth Design first reported a position in NUVB in Q3 2024 and has held it in 9 quarters since. The position peaked at $9.98K in Q4 2025. 13 funds tracked by Wall St. Rank hold NUVB as of Q3 2026.

  • True Wealth Design held 1,119 shares of Nuvation Bio worth $6.27K as of Q3 2026.
  • True Wealth Design bought 8 Nuvation Bio shares in Q3 2026, an estimated $50.
  • Nuvation Bio made up ﹤0.01% of True Wealth Design's portfolio in Q3 2026, its #1254 holding.
  • True Wealth Design first reported a position in Nuvation Bio in Q3 2024 and has held it in 9 quarters since.
  • True Wealth Design's Nuvation Bio position peaked at $9.98K in Q4 2025.
  • 13 funds tracked by Wall St. Rank held Nuvation Bio as of Q3 2026.

Based on True Wealth Design's 13F filing for Q3 2026, filed 13 Oct 2026.